Fuyuki Kametani

9.7k total citations · 4 hit papers
196 papers, 6.6k citations indexed

About

Fuyuki Kametani is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Fuyuki Kametani has authored 196 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Molecular Biology, 93 papers in Physiology and 37 papers in Neurology. Recurrent topics in Fuyuki Kametani's work include Alzheimer's disease research and treatments (80 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (59 papers) and Prion Diseases and Protein Misfolding (30 papers). Fuyuki Kametani is often cited by papers focused on Alzheimer's disease research and treatments (80 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (59 papers) and Prion Diseases and Protein Misfolding (30 papers). Fuyuki Kametani collaborates with scholars based in Japan, United Kingdom and United States. Fuyuki Kametani's co-authors include Masato Hasegawa, Haruhiko Akiyama, Takashi Nonaka, Mari Yoshida, Tetsuaki Arai, Shuji Kitagawa, Shigeo Murayama, Shu‐ichi Ikeda, Alexey G. Murzin and Masahide Yazaki and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Fuyuki Kametani

190 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease

2018 634 citations Fuyuki Kametani, Masato Hasegawa profile →
Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

2008 592 citations Masato Hasegawa, Takashi Nonaka et al. profile →
Structures of α-synuclein filaments from multiple system atrophy

2020 510 citations Manuel Schweighauser, Yue‐De Yang et al. Nature profile →
Structure of pathological TDP-43 filaments from ALS with FTLD

2021 180 citations Diana Arseni, Masato Hasegawa et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fuyuki Kametani Japan	39	3.4k	3.1k	2.2k	787	748	196	6.6k
William E. Van Nostrand United States	49	3.6k 1.0×	6.4k 2.1×	1.3k 0.6×	2.1k 2.7×	1.2k 1.6×	152	8.8k
Maria Teresa Carrı̀ Italy	45	2.5k 0.7×	883 0.3×	2.9k 1.3×	835 1.1×	707 0.9×	112	5.5k
Sandra L. Siedlak United States	56	5.2k 1.5×	6.0k 1.9×	1.6k 0.7×	1.6k 2.0×	1.5k 2.0×	140	10.7k
Peter J. Crouch Australia	38	1.9k 0.6×	1.7k 0.6×	1.1k 0.5×	453 0.6×	444 0.6×	109	5.0k
Davide Trotti United States	41	2.5k 0.7×	1.1k 0.3×	2.3k 1.1×	952 1.2×	2.3k 3.1×	70	5.9k
William M. Pierce United States	54	5.2k 1.5×	3.2k 1.0×	443 0.2×	665 0.8×	842 1.1×	154	9.1k
Ward A. Pedersen United States	25	2.1k 0.6×	2.0k 0.6×	741 0.3×	587 0.7×	778 1.0×	37	4.6k
Steven Estus United States	44	4.4k 1.3×	4.4k 1.4×	446 0.2×	1.1k 1.3×	1.5k 2.1×	87	8.3k
Peggy L.R. Harris United States	37	3.2k 0.9×	4.1k 1.3×	551 0.3×	931 1.2×	884 1.2×	69	7.4k
W. Davis Parker United States	45	4.9k 1.4×	2.7k 0.9×	2.7k 1.2×	903 1.1×	2.3k 3.0×	70	8.2k

Countries citing papers authored by Fuyuki Kametani

Since Specialization

Citations

This map shows the geographic impact of Fuyuki Kametani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuyuki Kametani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuyuki Kametani more than expected).

Fields of papers citing papers by Fuyuki Kametani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuyuki Kametani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuyuki Kametani. The network helps show where Fuyuki Kametani may publish in the future.

Co-authorship network of co-authors of Fuyuki Kametani

This figure shows the co-authorship network connecting the top 25 collaborators of Fuyuki Kametani. A scholar is included among the top collaborators of Fuyuki Kametani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuyuki Kametani. Fuyuki Kametani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hata, Yukiko, Tsuneaki Yoshinaga, Nagaaki Katoh, et al.. (2024). Amyloid-Forming Corpora Amylacea and Spheroid-Type Amyloid Deposition: Comprehensive Analysis Using Immunohistochemistry, Proteomics, and a Literature Review. Preprints.org. 1 indexed citations

Katoh, Nagaaki, Fuyuki Kametani, Masahide Yazaki, et al.. (2024). Enterocolic granulomatous phlebitis associated with epidermal growth factor‐containing fibulin‐like extracellular matrix protein 1 deposition and focal amyloid properties: A case report. Pathology International. 74(3). 146–153. 4 indexed citations

Tarutani, Airi, Fuyuki Kametani, Yuko Saito, et al.. (2023). Distinct tau folds initiate templated seeding and alter the post-translational modification profile. Brain. 146(12). 4988–4999. 8 indexed citations

Arseni, Diana, Alexey G. Murzin, Sew‐Yeu Peak‐Chew, et al.. (2023). TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP. Nature. 620(7975). 898–903. 72 indexed citations

Araki, Wataru & Fuyuki Kametani. (2022). Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer’s Disease Dementia. Antioxidants. 11(1). 132–132. 12 indexed citations

Kametani, Fuyuki, Ryoji Ito, Banri Tsuda, et al.. (2021). HER2-antigen-specific humoral immune response in breast cancer lymphocytes transplanted in hu-PBL hIL-4 NOG mice. Scientific Reports. 11(1). 12798–12798. 4 indexed citations

Kametani, Fuyuki, et al.. (2021). Curcumin promotes AApoAII amyloidosis and peroxisome proliferation in mice by activating the PPARα signaling pathway. eLife. 10. 18 indexed citations

Shimizu, Takuto, Yuka Ito, Kazuo Morikawa, et al.. (2021). Volatile Anesthetic Sevoflurane Precursor 1,1,1,3,3,3-Hexafluoro-2-Propanol (HFIP) Exerts an Anti-Prion Activity in Prion-Infected Culture Cells. Neurochemical Research. 46(8). 2056–2065. 4 indexed citations

Arseni, Diana, Masato Hasegawa, Alexey G. Murzin, et al.. (2021). Structure of pathological TDP-43 filaments from ALS with FTLD. Nature. 601(7891). 139–143. 180 indexed citations breakdown →

10.

Schweighauser, Manuel, Yue‐De Yang, Airi Tarutani, et al.. (2020). Structures of α-synuclein filaments from multiple system atrophy. Nature. 585(7825). 464–469. 510 indexed citations breakdown →

11.

Aono, Yuya, Yasuhiro Hamatani, Nagaaki Katoh, et al.. (2020). Late-onset Hereditary ATTR Amyloidosis with a Novel p.P63S (P43S) Transthyretin Variant. Internal Medicine. 60(4). 557–561. 2 indexed citations

12.

Tsuji, Hiroshi, Takashi Nonaka, Makiko Yamashita, et al.. (2011). Epitope mapping of antibodies against TDP-43 and detection of protease-resistant fragments of pathological TDP-43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Biochemical and Biophysical Research Communications. 417(1). 116–121. 25 indexed citations

13.

Kametani, Fuyuki, et al.. (2006). Reticulons RTN3 and RTN4‐B/C interact with BACE1 and inhibit its ability to produce amyloid β‐protein. European Journal of Neuroscience. 24(5). 1237–1244. 106 indexed citations

14.

Yamamoto, Akihiro, Naruhiko Sahara, Mihoko Usami, et al.. (1996). Abnormal Gel-Electrophoretic Behavior of Presenilin I and Its Fragment. Biochemical and Biophysical Research Communications. 226(2). 536–541. 14 indexed citations

15.

Maruyama, Keiko, Fuyuki Kametani, Shu‐ichi Ikeda, Tokuhiro Ishihara, & Nobuo Yanagisawa. (1992). Characterization of amyloid fibril protein from a case of cerebral amyloid angiopathy showing immunohistochemical reactivity for both β protein and cystatin C. Neuroscience Letters. 144(1-2). 38–42. 32 indexed citations

16.

Kametani, Fuyuki, et al.. (1991). Amyloid β/A4 protein precursor of human glioma cell, Bu-17 . Biomedical Research. 12(5). 351–355. 2 indexed citations

17.

Kitagawa, Shuji, et al.. (1985). Effects of long-chain cis-unsaturated fatty acids and their alcohol analogs on aggregation of bovine platelets and their relation with membrane fluidity change. Biochimica et Biophysica Acta (BBA) - Biomembranes. 818(3). 391–397. 52 indexed citations

18.

Kametani, Fuyuki, et al.. (1983). Comparative studies on the structure of the light chains of human immunoglobulins. IV. Assignment of a subsubgroup.:IV. Assignment of a Subsubgroup. The Journal of Biochemistry. 93(2). 421–429. 11 indexed citations

19.

Terada, Hiroshi, Masayuki Uda, Fuyuki Kametani, & Seiju Kubota. (1978). Structural requirements of alkyl acyldithiocarbazates for the uncoupling of oxidative phosphorylation in mitochondria. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 504(2). 237–247. 11 indexed citations

20.

Terada, Hiroshi, et al.. (1977). Lipophilic dithiocarbazates as potent uncouplers of oxidative phosphorylation. FEBS Letters. 78(1). 77–80. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact